SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    A look at monthly cannabis sales in Canada

    By

    The CCSI was assessed at C$5.13 per gram this week, down 1.3% from last week’s C$5.20 per gram. This week’s price equates to US$1,833 per pound at the current exchange rate.

    cannabis news about the monthly cannabis sales in canada

    Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.

    This week, Cannabis Benchmarks examines updated household expenditure data issued quarterly by Statistics Canada. As seen in the chart above, in Q4 2021 the estimated household expenditure for legal recreational cannabis continued to grow, while estimated expenditures in the illicit market continued to contract.

    More Canadians are choosing to purchase cannabis through regulated legal channels, as awareness and accessibility continue to evolve. Also fueling that trend is the drop in prices, as new supplies from legal indoor and outdoor cultivation operations became available, making products from licensed businesses more price-competitive with those of illegal sellers.

    In Q4 2021, recreational cannabis expenditures grew 33% to C$1,224M and illicit cannabis expenditures dropped by 13% to C$660M compared to the same time frame in 2020. Cannabis Benchmarks also note that expenditures for medical-use cannabis dropped 13% to C$108M. Medical cannabis now makes up only 5.4% of the total Canadian cannabis market. Total expenditures on cannabis were C$1.993B for the quarter, or C$21.7M per day.

    Source: Canada Cannabis Spot IndexCannabis Benchmarks

    See previous weekly updates from Cannabis Benchmarks:



    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free